Airway Flow of RAM Cannula With BCPAP in Infants

June 19, 2025 updated by: Thomas Drevhammar, Karolinska Institutet

Observational Study of Breathing and Flows in Bubble-CPAP Used With the RAM Cannula Interface in Newborn Infants

The RAM Cannula interface is used as routine interface for newborn infants receiving CPAP treatment for respiratory distress. Compared to the standard systems that have been used for more than 50 years, the interface has high resistance and has not been extensively studied. The delivered quality of the CPAP support is likely to be negatively affected by the interface resistance.

We hypothesise that exhalations through the device is uncommon and that the interface resistance restricts flow from the patient. If expiratory flows are uncommon the RAM interface provide support clinically comparable to other systems based on unidirectional flow such as humidified high-flow cannula.

This is a cross-sectional, observational study (no intervention) in newborn infants that are clinically stable and on respiratory support with the RAM interface connected to a bCPAP circuit. This is the most common support in the Phu San neonatal unit. The time needed for data collection is short and collection is expected to take approximately five minutes (less than 15 minutes) in a quiet infant. The collection can be planned to minimize disturbances for the infant, parents and staff. For example, the busiest times of the day can be avoided to not intervene with daily care, ward rounds or examinations of the infant.

Data on flow and pressure will be collected within the respiratory support circuit at the connection to the RAM interface. The measurements are passive, and no tests or manipulation of the infant is planned. There will be brief interruptions (<1 min) in respiratory support when the meters are connected. Similar interruptions are very common and occurs several times per day during normal care.

Data will be collected in case report forms (CRF) with REDCap electronic data capture tool. All personal identifiers will be removed before data export from REDCap and further analysis only using enrolment numbers.

Background variables describing the pregnancy, delivery and the infant will be collected. We also will record details of the RAM-cannula interface, such as size, protective dressing, gastric feeding tube, obvious leak at nares and mouth.

During the measurement the infant will be monitored for vital signs and any problems will be addressed and recorded. This includes oxygen need, CPAP support and breathing problems. The flow and pressure data for one minute of quiet breathing will be stored locally with the enrolment number as identifier. The analysis after collection of flow and pressure will include average flow in the CPAP circuit, the flow to the patient, average absolute leak and delivered pressure. If a variation with breathing can be seen this will be described. These output variables directly relate to the research questions.

  1. What flows and pressure can be observed in the breathing circuit? [Measured average flows, pressure and variability between patients]
  2. Do infants exhale through the RAM interface? [Measured expiratory flows at the interface]
  3. What is the level of leak for the interface? [Measured absolute leak]

The RAM cannula interface has been widely introduced but is not CE-marked for CPAP support. It has an advantage of being more comfortable and light weight with less nasal injury in most trials. The high resistance of the RAM interface has been discussed as problematic by several authors, but the clinical importance is not known. Comparing RAM interface to other CPAP interfaces in clinical trials is difficult and, if RAM has a treatment effect similar to HHFNC, very large trials of high quality would be needed.

The described study will generate new knowledge on the RAM interface by describing patient flow through the interface and illustrate the importance of resistance and leak. The study is not strictly a physiological study but investigate flow in an airway interface. The most likely outcome is that exhalation is uncommon, and this would support that the RAM interface has more similarities with HHFNC than conventional CPAP.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Hien Vu, MD
  • Phone Number: +84 904 999 455
  • Email: hien.vu@ki.se

Study Contact Backup

Study Locations

      • Hanoi, Vietnam, 118000
        • Phu San Hanoi Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Infants treated with RAM interface and bubble CPAP system that are clinically stable, spontaneous breathing and not expected to need any urgent interventions.

Description

Inclusion Criteria:

  • Admitted to Phu San Hanoi Hospital Neonatology Unit
  • Support with bubble CPAP and RAM interface
  • Quiet and stable spontaneous breathing
  • Investigation team available

Exclusion Criteria:

  • Problems with routine CPAP care
  • Major congenital malformation
  • Known syndrome or neuromuscular disease
  • Circulatory instability with inotropes
  • Oxygen need >50% or CPAP >10 cm H2O
  • Surfactant given the last 6 hours or expected to be needed the next 6 hours
  • Expected to need NIPPV or intubation within 6 hours
  • Recently extubated (<24 h)
  • Recent large surgical procedure (<5 days)
  • Nasal wound or irritation that hurts or is at risk of worsening during study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Infant treated with bubble CPAP and receiving blended air/oxygen

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Airway flow in RAM interface
Time Frame: 60 seconds
Average airway flow (L/min) in a quiet breathing infant
60 seconds

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pressure at Y-piece connector of RAM interface
Time Frame: 60 seconds
Average pressure (cm H2O) over 60 seconds in a quiet breathing infant
60 seconds
Fresh gas flow to Y-piece connector for RAM interface
Time Frame: 60 seconds
Average flow (L/min) over 60 seconds in a quiet breathing infant
60 seconds
Exhalation through Y-piece connector for RAM interface
Time Frame: 60 seconds
Number of breaths (ratio) with an expiratory flow of (duration >0.1 ms) over 60 seconds in a quiet breathing infant
60 seconds

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adverse events
Time Frame: 1 hour
Any adverse events during the measurement
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 19, 2024

Primary Completion (Actual)

June 1, 2025

Study Completion (Actual)

June 1, 2025

Study Registration Dates

First Submitted

November 18, 2024

First Submitted That Met QC Criteria

November 18, 2024

First Posted (Actual)

November 20, 2024

Study Record Updates

Last Update Posted (Estimated)

June 25, 2025

Last Update Submitted That Met QC Criteria

June 19, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 1758 CN/PS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The datasets used and/or analysed during the current study will be available from the principal investigator on reasonable request after publication of results.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.